{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T17:52:34Z","timestamp":1786125154919,"version":"build-2736575974"},"reference-count":65,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1227\/neu.0000000000000018","type":"journal-article","created":{"date-parts":[[2013,6,11]],"date-time":"2013-06-11T08:29:31Z","timestamp":1370939371000},"page":"440-449","source":"Crossref","is-referenced-by-count":65,"title":["Cancer After Spinal Fusion"],"prefix":"10.1227","volume":"73","author":[{"given":"Shivanand P.","family":"Lad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob H.","family":"Bagley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac O.","family":"Karikari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranjith","family":"Babu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Ugiliweneza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maiying","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert E.","family":"Isaacs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos A.","family":"Bagley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oren N.","family":"Gottfried","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chirag G.","family":"Patil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxwell","family":"Boakye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"2","key":"-20230323","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1227\/01.NEU.0000363722.42097.C2","article-title":". Bone morphogenetic proteins and cancer: review of the literature.","volume":"66","author":"Thawani","year":"2010","journal-title":"Neurosurgery"},{"issue":"6","key":"-20230323","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.spinee.2011.04.023","article-title":"A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned.","volume":"11","author":"Carragee","year":"2011","journal-title":"Spine J"},{"issue":"6","key":"-20230323","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.spinee.2011.04.023","article-title":"A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned.","volume":"11","author":"Carragee","year":"2011","journal-title":"Spine J"},{"issue":"23","key":"R1-8-20230323","first-page":"2707","article-title":"United States trends and regional variations in lumbar spine surgery: 1992-2003. Spine (Phila Pa 1976).","volume":"31","author":"Weinstein","year":"2006","journal-title":""},{"issue":"24","key":"R2-8-20230323","first-page":"2807","article-title":"1997 Volvo Award winner in clinical studies: degenerative lumbar spondylolisthesis with spinal stenosis: a prospective, randomized study comparing decompressive laminectomy and arthrodesis with and without spinal instrumentation. Spine (Phila Pa 1976).","volume":"22","author":"Fischgrund","year":"1997","journal-title":""},{"issue":"3","key":"R4-8-20230323","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3171\/2011.4.SPINE10330","article-title":"Meta-analysis of instrumented posterior interbody fusion versus instrumented posterolateral fusion in the lumbar spine.","volume":"15","author":"Zhou","year":"2011","journal-title":"J Neurosurg Spine"},{"issue":"8","key":"R5-8-20230323","doi-asserted-by":"crossref","first-page":"494","DOI":"10.5435\/00124635-200908000-00003","article-title":"Pseudarthrosis of the spine.","volume":"17","author":"Raizman","year":"2009","journal-title":"J Am Acad Orthop Surg"},{"issue":"3","key":"R7-8-20230323","first-page":"382","article-title":"Reoperation rates following lumbar spine surgery and the influence of spinal fusion procedures. Spine (Phila Pa 1976).","volume":"32","author":"Martin","year":"2007","journal-title":""},{"issue":"4","key":"R8-8-20230323","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3171\/2011.4.SPINE10822","article-title":". Long-term outcomes of revision fusion for lumbar pseudarthrosis: clinical article.","volume":"15","author":"Adogwa","year":"2011","journal-title":"J Neurosurg Spine"},{"issue":"4","key":"R9-8-20230323","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3171\/2011.12.SPINE11750","article-title":"Factors influencing 2-year health care costs in patients undergoing revision lumbar fusion procedures.","volume":"16","author":"Parker","year":"2012","journal-title":"J Neurosurg Spine"},{"issue":"9","key":"R10-8-20230323","first-page":"942","article-title":"The rate of pseudarthrosis (surgical nonunion) in patients who are smokers and patients who are nonsmokers: a comparison study. Spine (Phila Pa 1976).","volume":"11","author":"Brown","year":"1986","journal-title":""},{"issue":"5","key":"R11-8-20230323","doi-asserted-by":"crossref","first-page":"668","DOI":"10.2106\/00004623-200105000-00004","article-title":"Impact of smoking on the outcome of anterior cervical arthrodesis with interbody or strut-grafting.","volume":"83-A","author":"Hilibrand","year":"2001","journal-title":"J Bone Joint Surg Am"},{"issue":"18","key":"R14-8-20230323","first-page":"2048","article-title":"A prospective analysis of autograft versus allograft in posterolateral lumbar fusion in the same patient: a minimum of 1-year follow-up in 144 patients. Spine (Phila Pa 1976).","volume":"19","author":"Jorgenson","year":"1994","journal-title":""},{"issue":"4","key":"R15-8-20230323","first-page":"372","article-title":"Radiographic assessment of interbody fusion using recombinant human bone morphogenetic protein type 2. Spine (Phila Pa 1976).","volume":"28","author":"Burkus","year":"2003","journal-title":""},{"issue":"5","key":"R16-8-20230323","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.2106\/JBJS.G.01485","article-title":"Six-year outcomes of anterior lumbar interbody arthrodesis with use of interbody fusion cages and recombinant human bone morphogenetic protein-2.","volume":"91","author":"Burkus","year":"2009","journal-title":"J Bone Joint Surg Am"},{"issue":"21","key":"R17-8-20230323","first-page":"2396","article-title":"Clinical and radiographic outcomes of anterior lumbar interbody fusion using recombinant human bone morphogenetic protein-2. Spine (Phila Pa 1976).","volume":"27","author":"Burkus","year":"2002","journal-title":""},{"issue":"26","key":"R20-8-20230323","first-page":"2354","article-title":"Outcomes for single-level lumbar fusion: the role of bone morphogenetic protein. Spine (Phila Pa 1976).","volume":"36","author":"Cahill","year":"2011","journal-title":""},{"issue":"12","key":"R21-8-20230323","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1001\/jama.2011.1371","article-title":"Questions about spine fusion product prompt a new process for reviewing data.","volume":"306","author":"Mitka","year":"2011","journal-title":"JAMA"},{"issue":"6","key":"R22-8-20230323","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.spinee.2011.04.023","article-title":"A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned.","volume":"11","author":"Carragee","year":"2011","journal-title":"Spine J"},{"issue":"6","key":"R23-8-20230323","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.spinee.2011.02.013","article-title":"Retrograde ejaculation after anterior lumbar interbody fusion using rhBMP-2: a cohort controlled study.","volume":"11","author":"Carragee","year":"2011","journal-title":"Spine J"},{"issue":"3","key":"R24-8-20230323","doi-asserted-by":"crossref","first-page":"296","DOI":"10.3171\/2011.11.SPINE11629","article-title":"Bone morphogenetic protein-induced inflammatory cyst formation after lumbar fusion causing nerve root compression.","volume":"16","author":"Choudhry","year":"2012","journal-title":"J Neurosurg Spine"},{"issue":"7","key":"R26-8-20230323","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1007\/s00586-008-0651-8","article-title":". Association of bone morphogenetic protein-2 gene polymorphisms with susceptibility to ossification of the posterior longitudinal ligament of the spine and its severity in Chinese patients.","volume":"17","author":"Wang","year":"2008","journal-title":"Eur J Spine"},{"issue":"1","key":"R27-8-20230323","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3171\/2009.4.SPINE0876","article-title":"Symptomatic ectopic bone formation after off-label use of recombinant human bone morphogenetic protein-2 in transforaminal lumbar interbody fusion.","volume":"12","author":"Chen","year":"2010","journal-title":"J Neurosurg Spine"},{"issue":"25","key":"R28-8-20230323","first-page":"2885","article-title":"Heterotopic bone formation with the use of rhBMP2 in posterior minimal access interbody fusion: a CT analysis. Spine (Phila Pa 1976).","volume":"32","author":"Joseph","year":"2007","journal-title":""},{"issue":"4","key":"R30-8-20230323","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1007\/s00586-010-1494-7","article-title":"Perioperative complications with rhBMP-2 in transforaminal lumbar interbody fusion.","volume":"20","author":"Owens","year":"2011","journal-title":"Eur J Spine"},{"issue":"7","key":"R31-8-20230323","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/01.bsd.0000211231.83716.4b","article-title":"Vertebral bone resorption after transforaminal lumbar interbody fusion with bone morphogenetic protein (rhBMP-2).","volume":"19","author":"McClellan","year":"2006","journal-title":"J Spinal Disord Tech"},{"issue":"24","key":"R33-8-20230323","first-page":"2813","article-title":"Increased swelling complications associated with off-label usage of rhBMP-2 in the anterior cervical spine. Spine (Phila Pa 1976).","volume":"31","author":"Smucker","year":"2006","journal-title":""},{"issue":"5","key":"R35-8-20230323","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.spinee.2007.01.011","article-title":"Vertebral osteolysis after posterior interbody lumbar fusion with recombinant human bone morphogenetic protein 2: a report of five cases.","volume":"7","author":"Lewandrowski","year":"2007","journal-title":"Spine J"},{"issue":"4","key":"R37-8-20230323","first-page":"E274","article-title":"Trends in the use of bone morphogenetic protein as a substitute to autologous iliac crest bone grafting for spinal fusion procedures in the United States. Spine (Phila Pa 1976).","volume":"36","author":"Lad","year":"2011","journal-title":""},{"issue":"19","key":"R38-8-20230323","first-page":"1794","article-title":"Off-label use of bone morphogenetic proteins in the United States using administrative data. Spine (Phila Pa 1976).","volume":"35","author":"Ong","year":"2010","journal-title":""},{"issue":"4","key":"R39-8-20230323","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1159\/000335424","article-title":"Recombinant human bone morphogenetic protein-2 as an adjunct for spine fusion in a pediatric population.","volume":"47","author":"Abd-El-Barr","year":"2011","journal-title":"Pediatr Neurosurg"},{"issue":"2","key":"R41-8-20230323","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4103\/0974-8237.77674","article-title":"Use of recombinant human bone morphogenetic protein-2 as an adjunct for instrumented posterior arthrodesis in the occipital cervical region: an analysis of safety, efficacy, and dosing.","volume":"1","author":"Hamilton","year":"2010","journal-title":"J Craniovertebr Junction Spine"},{"issue":"6","key":"R43-8-20230323","first-page":"527","article-title":"Promoting fusion in minimally invasive lumbar interbody stabilization with low-dose bone morphogenic protein-2: but what is the cost Spine J.","volume":"11","author":"Mannion","year":"2011","journal-title":""},{"issue":"5","key":"R44-8-20230323","doi-asserted-by":"crossref","first-page":"468","DOI":"10.3171\/2011.2.PEDS10487","article-title":"Complications associated with recombinant human bone morphogenetic protein use in pediatric craniocervical arthrodesis.","volume":"7","author":"Lindley","year":"2011","journal-title":"J Neurosurg Pediatr"},{"issue":"7","key":"R47-8-20230323","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1001\/jama.294.7.797","article-title":"Impact of varicella vaccination on health care utilization.","volume":"294","author":"Zhou","year":"2005","journal-title":"JAMA"},{"issue":"8","key":"R48-8-20230323","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.amjcard.2011.12.001","article-title":"Age-specific gender differences in in-hospital mortality by type of acute myocardial infarction.","volume":"109","author":"Zhang","year":"2012","journal-title":"Am J Cardiol"},{"issue":"12","key":"R49-8-20230323","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1056\/NEJMoa1000446","article-title":". Rotavirus vaccine and health care utilization for diarrhea in U.S. children.","volume":"365","author":"Cortes","year":"2011","journal-title":"N Engl J Med"},{"issue":"1","key":"R50-8-20230323","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/biomet\/70.1.41","article-title":"The central role of propensity scores in observational studies for causal effects.","volume":"70","author":"Rosenbaum","year":"1983","journal-title":"Biometrika"},{"issue":"21","key":"R51-8-20230323","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1001\/archinte.163.21.2576","article-title":". In-hospital initiation of lipid-lowering therapy after coronary intervention as a predictor of long-term utilization: a propensity analysis.","volume":"163","author":"Aronow","year":"2003","journal-title":"Arch Intern Med"},{"issue":"9","key":"R52-8-20230323","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1056\/NEJMoa022353","article-title":"Frequent ventricular ectopy after exercise as a predictor of death.","volume":"348","author":"Frolkis","year":"2003","journal-title":"N Engl J Med"},{"issue":"10","key":"R53-8-20230323","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/j.amjcard.2011.06.066","article-title":". A propensity-matched study of the comparative effectiveness of angiotensin receptor blockers versus angiotensin-converting enzyme inhibitors in heart failure patients age 65 years.","volume":"108","author":"Zhang","year":"2011","journal-title":"Am J Cardiol"},{"issue":"3","key":"R54-8-20230323","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/PSY.0b013e3182114d35","article-title":". Gender differences in health-related quality of life after coronary bypass surgery: results from a 1-year follow-up in propensity-matched men and women.","volume":"73","author":"Kendel","year":"2011","journal-title":"Psychosom Med"},{"issue":"5","key":"R55-8-20230323","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"issue":"6","key":"R56-8-20230323","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","article-title":"Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases.","volume":"45","author":"Deyo","year":"1992","journal-title":"J Clin Epidemiol"},{"issue":"11","key":"R57-8-20230323","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":". Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data.","volume":"43","author":"Quan","year":"2005","journal-title":"Med Care"},{"issue":"10","key":"R58-8-20230323","doi-asserted-by":"crossref","first-page":"619","DOI":"10.5483\/BMBRep.2011.44.10.619","article-title":"BMPs and their clinical potentials.","volume":"44","author":"Kim","year":"2011","journal-title":"BMB Rep"},{"issue":"4","key":"R59-8-20230323","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.cytogfr.2010.06.003","article-title":"The Yin and Yang of bone morphogenetic proteins in cancer.","volume":"21","author":"Singh","year":"2010","journal-title":"Cytokine Growth Factor Rev"},{"issue":"10","key":"R60-8-20230323","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/jjco\/hyp094","article-title":"Expression pattern and clinical prognostic relevance of bone morphogenetic protein-2 in human gliomas.","volume":"39","author":"Liu","year":"2009","journal-title":"Jpn J Clin Oncol"},{"issue":"5","key":"R61-8-20230323","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/S0016-5085(99)70024-7","article-title":". Bone morphogenetic protein 2 exerts diverse effects on cell growth in vitro and is expressed in human pancreatic cancer in vivo.","volume":"116","author":"Kleeff","year":"1999","journal-title":"Gastroenterology"},{"issue":"1","key":"R62-8-20230323","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.canlet.2008.02.034","article-title":"Molecular profiling of bladder cancer: involvement of the TGF-beta pathway in bladder cancer progression.","volume":"265","author":"Hung","year":"2008","journal-title":"Cancer Lett"},{"issue":"3","key":"R63-8-20230323","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/sj.bjc.6602933","article-title":". Gene expression profiling of primary cultures of ovarian epithelial cells identifies novel molecular classifiers of ovarian cancer.","volume":"94","author":"Le Page","year":"2006","journal-title":"Br J Cancer"},{"issue":"3","key":"R64-8-20230323","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1158\/1541-7786.141.2.3","article-title":"Bone morphogenetic protein-2 stimulates angiogenesis in developing tumors.","volume":"2","author":"Langenfeld","year":"2004","journal-title":"Mol Cancer Res"},{"issue":"3","key":"R65-8-20230323","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.lungcan.2009.02.020","article-title":"The positive correlation between gene expression of the two angiogenic factors: VEGF and BMP-2 in lung cancer patients.","volume":"66","author":"Bieniasz","year":"2009","journal-title":"Lung Cancer"},{"issue":"28","key":"R66-8-20230323","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.1038\/sj.onc.1210182","article-title":"Functional implication of BMP4 expression on angiogenesis in malignant melanoma.","volume":"26","author":"Rothhammer","year":"2007","journal-title":"Oncogene"},{"issue":"1","key":"R67-8-20230323","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/jcb.10679","article-title":"Bone morphogenetic protein signaling in prostate cancer cell lines.","volume":"91","author":"Brubaker","year":"2004","journal-title":"J Cell Biochem"},{"issue":"22","key":"R68-8-20230323","first-page":"5022","article-title":". Growth regulation of human prostate cancer cells by bone morphogenetic protein-2.","volume":"57","author":"Ide","year":"1997","journal-title":"Cancer Res"},{"issue":"4","key":"R69-8-20230323","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/00001813-199804000-00006","article-title":". Antiproliferative effects of recombinant human bone morphogenetic protein-2 on human tumor colony-forming units.","volume":"9","author":"Soda","year":"1998","journal-title":"Anticancer Drugs"},{"issue":"18","key":"R70-8-20230323","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1038\/sj.onc.1209297","article-title":"Frequent epigenetic silencing of the bone morphogenetic protein 2 gene through methylation in gastric carcinomas.","volume":"25","author":"Wen","year":"2006","journal-title":"Oncogene"},{"issue":"12","key":"R71-8-20230323","doi-asserted-by":"crossref","first-page":"4126","DOI":"10.1096\/fj.08-127795","article-title":"In vitro and in vivo imaging of antivasculogenesis induced by Noggin protein expression in human venous endothelial cells.","volume":"23","author":"Kang","year":"2009","journal-title":"FASEB J"},{"issue":"4","key":"R72-8-20230323","first-page":"E237","article-title":"Temporal and spatial expression of BMPs and BMP antagonists during posterolateral lumbar fusion. Spine (Phila Pa 1976).","volume":"36","author":"Tang","year":"2011","journal-title":""},{"issue":"4","key":"R73-8-20230323","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1359\/jbmr.2000.15.4.663","article-title":". Essential requirement of BMPs-24 for both osteoblast and osteoclast formation in murine bone marrow cultures from adult mice: antagonism by noggin.","volume":"15","author":"Abe","year":"2000","journal-title":"J Bone Miner Res"},{"issue":"11","key":"R74-8-20230323","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1359\/jbmr.1999.14.11.1805","article-title":"Growth factor regulation of fracture repair.","volume":"14","author":"Barnes","year":"1999","journal-title":"J Bone Miner Res"},{"issue":"12","key":"R75-8-20230323","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1097\/00005650-199112000-00005","article-title":"Accuracy of Medicare claims data for estimation of cancer incidence and resection rates among elderly Americans.","volume":"29","author":"Whittle","year":"1991","journal-title":"Med Care"},{"issue":"2","key":"R76-8-20230323","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2105\/AJPH.86.2.243","article-title":"The validity of hospital administrative data in monitoring variations in breast cancer surgery.","volume":"86","author":"Kahn","year":"1996","journal-title":"Am J Public Health"},{"issue":"5","key":"R77-8-20230323","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/00005650-199905000-00003","article-title":"The sensitivity of Medicare claims data for case ascertainment of six common cancers.","volume":"37","author":"Cooper","year":"1999","journal-title":"Med Care"}],"container-title":["Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/neurosurgery\/article-pdf\/73\/3\/440\/32594321\/neurosurgery-73-3-440.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/www.ovid.com\/00006123-201309000-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:51:02Z","timestamp":1786121462000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006123-201309000-00008"}},"subtitle":["The Role of Bone Morphogenetic Protein"],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":65,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1227\/neu.0000000000000018","relation":{},"ISSN":["0148-396X"],"issn-type":[{"value":"0148-396X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]}}}